General Info

Adeona Pharmaceuticals is a development-stage, specialty pharmaceutical company that develops orally active, proprietary, late-stage drug candidates for the treatment of autoimmune diseases and central nervous system diseases. It focuses on the development of oral therapies for the treatment of rheumatoid arthritis, multiple sclerosis and age-related macular degeneration. The company manufactures Trimesta, which is as an oral, immunomodulatory and anti-inflammatory agent for the North American market. Adeona Pharmaceuticals also develops a series of rationally designed and small-molecule inhibitors. It additionally offers oral flupirtine that is a centrally active oral therapy for the treatment of fibromyalgia syndrome. The company has operations throughout Michigan.